Replies to post #413479 on Amarin Corp Plc (AMRN)

[CaptBeer]

doctors have always been slow on the uptake. Even after 30 years of statin R&D only a very small percentage of patients are adherent to LDL-c Guidelines. Branded statins are not advertised anymore because all of them are generic. Unfortunately for VASCEPA, the blood suckers' bit before most doctors ever heard about the benefits of VASCEPA. Fortunately, we have 8+2+1 years of exclusivity in Europe before those bandits can even begin.

[JRoon71]

RMB, you are correct. With zero marketing, we are just going to sort of float sideways for the indefinite future. Until/unless we make some headway with infringement, thee is no way they implement any type of marketing process again. We can make up SOME market share with exclusive insurance agreements, etc. But without any marketing, the magnitude is going to be very, very modest.